NasdaqGM - Nasdaq Real Time Price USD

Trevi Therapeutics, Inc. (TRVI)

7.06
+0.32
+(4.75%)
At close: June 6 at 4:00:00 PM EDT
7.07
+0.01
+(0.14%)
After hours: June 6 at 7:41:16 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
110,900
89,403
123,015
38,475
Total Liabilities Net Minority Interest
11,256
6,856
15,556
21,400
Total Equity Gross Minority Interest
99,644
82,547
107,459
17,075
Total Capitalization
99,644
82,547
109,610
25,727
Common Stock Equity
99,644
82,547
107,459
17,075
Capital Lease Obligations
1,032
1,338
27
144
Net Tangible Assets
99,644
82,547
107,459
17,075
Working Capital
98,919
81,723
109,216
25,233
Invested Capital
99,644
82,547
116,610
31,560
Tangible Book Value
99,644
82,547
107,459
17,075
Total Debt
1,032
1,338
9,178
14,629
Share Issued
93,602.63
68,283.70
59,943.43
28,505.80
Ordinary Shares Number
93,602.63
68,283.70
59,943.43
28,505.80
12/31/2021 - 5/7/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANAB AnaptysBio, Inc.
23.70
+12.11%
 
NKTR Nektar Therapeutics
0.6660
-1.30%
 
BCAX Bicara Therapeutics Inc.
11.50
+4.26%
 
CRVS Corvus Pharmaceuticals, Inc.
3.9100
0.00%
 
PTGX Protagonist Therapeutics, Inc.
54.38
+1.04%
 
SRRK Scholar Rock Holding Corporation
34.23
-0.06%
 
RGNX REGENXBIO Inc.
9.61
+14.95%
 
MRUS Merus N.V.
56.21
+0.36%
 
MREO Mereo BioPharma Group plc
2.7400
+11.38%
 
COGT Cogent Biosciences, Inc.
6.80
+13.52%